You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 165 No. 20, November 14, 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Aging/ Geriatrics
 •Thrombolysis
 •Cardiovascular System
 •Cardiovascular Disease/ Myocardial Infarction
 •Adverse Effects
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Bleeding Complications in Elderly Patients Following Acute Myocardial Infarction

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The article by Buresly and colleagues1 adds valuable information about the safety of combining aspirin with thienopyridine derivatives and/or warfarin in elderly patients receiving routine clinical care. Three points are relevant and complementary to the data presented in their study.

First, I could locate only 1 other publication that addresses the use of the 3-drug combination of aspirin, clopidogrel, and warfarin in a nontrial setting.2 This study evaluated outcomes in 66 patients who were given the 3-drug combination following percutaneous coronary intervention with stent placement. Six of these patients had a bleeding event. Of the 6 bleeding events, 4 were serious enough to warrant hospital readmission.2

A second important issue is the need to balance the potential risks and benefits of antiplatelet therapy and anticoagulation for older adults. This remains a major challenge for clinicians. Therefore, in addition to comparing harms (bleeding events), future studies might also consider evaluating whether . . . [Full Text of this Article]


AUTHOR INFORMATION
Sudeep S. Gill, MD, MSc, FRCPC



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Bleeding Complications Associated With Combinations of Aspirin, Thienopyridine Derivatives, and Warfarin in Elderly Patients Following Acute Myocardial Infarction
Khaled Buresly, Mark J. Eisenberg, Xun Zhang, and Louise Pilote
Arch Intern Med. 2005;165(7):784-789.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.